Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 54
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Oncogene ; 36(39): 5484-5496, 2017 09 28.
Artículo en Inglés | MEDLINE | ID: mdl-28534513

RESUMEN

Protein disulfide isomerase a4 (PDIA4) is implicated in the growth and death of tumor cells; however, its molecular mechanism and therapeutic potential in cancer are unclear. Here, we found that PDIA4 expression was upregulated in a variety of tumor cell lines and human lung adenocarcinoma tissues. Knockdown and overexpression of PDIA4 in tumor cells showed that PDIA4 facilitated cell growth via the reduction of caspases 3 and 7 activity. Consistently, Lewis lung carcinoma cells overexpressing PDIA4 grew faster than did parental cells in tumor-bearing mice, as shown by a reduced survival rate, increased tumor size and metastasis, and decreased cell death and caspases 3 and 7 activity. PDIA4 knockdown resulted in opposite outcomes. Moreover, results obtained in mice with spontaneous hepatoma indicated that PDIA4 deficiency significantly reduced hepatic tumorigenesis and cyst formation and increased mouse survival, tumor death, and caspases 3 and 7 activity. Mechanistic studies illustrated that PDIA4 negatively regulated tumor cell death by inhibiting degradation and activation of procaspases 3 and 7 via their mutual interaction in a CGHC-dependent manner. Finally, we found that 1,2-dihydroxytrideca-5,7,9,11-tetrayne, a PDIA4 inhibitor, reduced tumor development via enhancement of caspase-mediated cell death in TSA tumor-bearing mice. These findings characterize PDIA4 as a negative regulator of cancer cell apoptosis and suggest that PDIA4 is a potential therapeutic target for cancer.


Asunto(s)
Caspasas/metabolismo , Precursores Enzimáticos/metabolismo , Proteína Disulfuro Isomerasas/metabolismo , Animales , Línea Celular Tumoral , Femenino , Células HEK293 , Células Hep G2 , Humanos , Células Jurkat , Células MCF-7 , Masculino , Melanoma Experimental , Ratones , Ratones Endogámicos BALB C , Ratones Endogámicos C57BL
2.
Oncogene ; 36(31): 4405-4414, 2017 08.
Artículo en Inglés | MEDLINE | ID: mdl-28368406

RESUMEN

The epithelial-mesenchymal transition (EMT) is an important process in the progression of cancer. However, its occurrence and mechanism of regulation are not fully understood. We propose a regulatory pathway in which spermatogenic leucine zipper 1 (SPZ1) promotes EMT through its transactivating ability in increasing TWIST1 expression. We compared the expression of SPZ1 and TWIST1 in specimens of hepatocarcinoma cells (HCCs) and non-HCCs. Expression of SPZ1 exhibited a tumor-specific expression pattern and a high correlation with patients' survival time, tumor size, tumor number and progression stage. Moreover, forced expression and knockdown of SPZ1 in hepatoma cells showed that SPZ1 was able to regulate the cellular proliferation, invasion, and tumorigenic activity in a TWIST1-dependent manner in vitro and in vivo. These data demonstrate that SPZ1, a newly dscribed molecule, transactivates TWIST1 promoters, and that this SPZ1-TWIST axis mediates EMT signaling and exerts significant regulatory effects on tumor oncogenesis.


Asunto(s)
Factores de Transcripción Básicos con Cremalleras de Leucinas y Motivos Hélice-Asa-Hélice/fisiología , Carcinoma Hepatocelular/patología , Transición Epitelial-Mesenquimal , Neoplasias Hepáticas/patología , Proteínas Nucleares/fisiología , Proteína 1 Relacionada con Twist/fisiología , Adulto , Anciano , Anciano de 80 o más Años , Carcinogénesis , Carcinoma Hepatocelular/etiología , Línea Celular Tumoral , Proliferación Celular , Femenino , Humanos , Neoplasias Hepáticas/etiología , Masculino , Persona de Mediana Edad , Proteínas Nucleares/genética , Proteína 1 Relacionada con Twist/genética
3.
Cell Death Dis ; 4: e907, 2013 Nov 07.
Artículo en Inglés | MEDLINE | ID: mdl-24201806

RESUMEN

The androgen receptor (AR) has a critical role in promoting androgen-dependent and -independent apoptosis in testicular cells. However, the molecular mechanisms that underlie the ligand-independent apoptosis, including the activity of AR in testicular stem cells, are not completely understood. In the present study, we generated induced pluripotent stem cells (iPSCs) from bovine testicular cells by electroporation of octamer-binding transcription factor 4 (OCT4). The cells were supplemented with leukemia inhibitory factor and bone morphogenetic protein 4, which maintained and stabilized the expression of stemness genes and pluripotency. The iPSCs were used to assess the apoptosis activity following exposure to phthalate esters, including di (2-ethyhexyl) phthalates, di (n-butyl) phthalate, and butyl benzyl phthalate. Phthalate esters significantly reduced the expression of AR in iPSCs and induced a higher ratio of BAX/BCL-2, thereby favoring apoptosis. Phthalate esters also increased the expression of cyclin-dependent kinase inhibitor 1 (p21(Cip1)) in a p53-dependent manner and enhanced the transcriptional activity of p53. The forced expression of AR and knockdown of p21(Cip1) led to the rescue of the phthalate-mediated apoptosis. Overall, this study suggests that testicular iPSCs are a useful system for screening the toxicity of environmental disruptors and examining their effect on the maintenance of stemness and pluripotency, as well as for identifying the iPSC signaling pathway(s) that are deregulated by these chemicals.


Asunto(s)
Células Madre Pluripotentes Inducidas/efectos de los fármacos , Células Madre Pluripotentes Inducidas/metabolismo , Ácidos Ftálicos/farmacología , Receptores Androgénicos/metabolismo , Testículo/citología , Animales , Apoptosis/efectos de los fármacos , Apoptosis/genética , Bovinos , Reprogramación Celular/efectos de los fármacos , Reprogramación Celular/genética , Células Madre Pluripotentes Inducidas/citología , Masculino , Receptores Androgénicos/genética , Transducción de Señal/efectos de los fármacos , Proteína p53 Supresora de Tumor
4.
Cell Death Dis ; 4: e921, 2013 Nov 14.
Artículo en Inglés | MEDLINE | ID: mdl-24232097

RESUMEN

Oxidative stress and reactive oxygen species (ROS) are associated with diseases such as cancer, cardiovascular complications, inflammation and neurodegeneration. Cellular defense systems must work constantly to control ROS levels and to prevent their accumulation. We report here that the Jun dimerization protein 2 (JDP2) has a critical role as a cofactor for transcription factors nuclear factor-erythroid 2-related factor 2 (Nrf2) and small Maf protein family K (MafK) in the regulation of the antioxidant-responsive element (ARE) and production of ROS. Chromatin immunoprecipitation-quantitative PCR (qPCR), electrophoresis mobility shift and ARE-driven reporter assays were carried out to examine the role of JDP2 in ROS production. JDP2 bound directly to the ARE core sequence, associated with Nrf2 and MafK (Nrf2-MafK) via basic leucine zipper domains, and increased DNA-binding activity of the Nrf2-MafK complex to the ARE and the transcription of ARE-dependent genes. In mouse embryonic fibroblasts from Jdp2-knockout (Jdp2 KO) mice, the coordinate transcriptional activation of several ARE-containing genes and the ability of Nrf2 to activate expression of target genes were impaired. Moreover, intracellular accumulation of ROS and increased thickness of the epidermis were detected in Jdp2 KO mice in response to oxidative stress-inducing reagents. These data suggest that JDP2 is required to protect against intracellular oxidation, ROS activation and DNA oxidation. qPCR demonstrated that several Nrf2 target genes such as heme oxygenase-1, glutamate-cysteine ligase catalytic and modifier subunits, the notch receptor ligand jagged 1 and NAD(P)H dehydrogenase quinone 1 are also dependent on JDP2 for full expression. Taken together, these results suggest that JDP2 is an integral component of the Nrf2-MafK complex and that it modulates antioxidant and detoxification programs by acting via the ARE.


Asunto(s)
Factor de Transcripción MafK/metabolismo , Factor 2 Relacionado con NF-E2/metabolismo , Especies Reactivas de Oxígeno/metabolismo , Proteínas Represoras/metabolismo , Western Blotting , Inmunoprecipitación de Cromatina , Ensayo de Cambio de Movilidad Electroforética , Técnica del Anticuerpo Fluorescente , Glutatión/metabolismo , Células Hep G2 , Humanos , Factor de Transcripción MafK/genética , Factor 2 Relacionado con NF-E2/genética , Unión Proteica , ARN Interferente Pequeño , Proteínas Represoras/genética
5.
Curr Mol Med ; 12(10): 1340-9, 2012 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-23016591

RESUMEN

Human amnion-derived cells possess great potential for the repair of human neural disorders, and recent studies have broadened the spectrum for applications because they exhibit the characteristics of multipotent stem cells. These cells express embryonic stem cell markers such as Oct4, Nanog, Sox2, SSEA-3, SSEA-4 and Rex1, and can differentiate into multiple primary germ layers both in vitro and in vivo. Moreover, induced pluripotent stem cells have been generated from amnion-derived cells by virus-mediated delivery of three or four pluripotency-relating transcription factors or by the introduction of only one transcription factor with electroporation. Because human amnion-derived cells are readily available, less likely to contain genetic aberrations and can be reprogrammed earlier and more efficiently than differentiated cells, they can be ideal resources as the donor pluripotent stem cells for therapeutic purposes. We discuss here the highlights of recent studies and potential applications of human amnion-derived multipotent stem cells to stem cell biology as well as to regenerative medicine in the field of aging, heart disease, diabetes and neural disorders.


Asunto(s)
Amnios/citología , Células Madre Pluripotentes Inducidas , Células Madre Multipotentes , Antígenos de Carbohidratos Asociados a Tumores/metabolismo , Diferenciación Celular , Células Madre Embrionarias , Hepatocitos/metabolismo , Proteínas de Homeodominio/metabolismo , Humanos , Factores de Transcripción de Tipo Kruppel/metabolismo , Miocitos Cardíacos/metabolismo , Proteína Homeótica Nanog , Factor 3 de Transcripción de Unión a Octámeros/metabolismo , Osteoblastos/metabolismo , Regeneración , Factores de Transcripción SOXB1/metabolismo , Antígenos Embrionarios Específico de Estadio/metabolismo
6.
Curr Mol Med ; 11(6): 439-52, 2011 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-21663590

RESUMEN

Abnormal and prolonged inflammatory reaction is seen in a wide variety of disorders, and high level of Tumor Necrosis Factor alpha (TNF-α) has been linked to these disorders. Therefore, modulation of TNF-α expression is important in the regulation of inflammatory disorders. In our previous study, we have shown that a transcription factor LPS-induced TNF factor (LITAF) significantly induces TNF-α production. Furthermore, we found that p53 and its synthetic peptide 162-motif specifically downregulate LITAF/TNF-α gene expression in human cells in vitro. Thus, in the present study, the role of p53 in regulating TNF-α-mediated inflammation was investigated. Our data showed that a synthetic peptide, named 162-motif, corresponding to this region functions independently from p53 to cause a significant suppression of TNF-α gene expression in mouse primary macrophages. The 162-motif, when delivered into cells and organs, reduces serum TNF-α level in mice and prevents TNF-α-induced lung lesions and endotoxic shock. Our findings highlight the regulation of LITAF/TNF-α by p53 and its short peptide 162-motif. These in vitro and in vivo observations serve to pave the way for pharmacotherapeutic approaches in the treatment of inflammatory diseases.


Asunto(s)
Proteínas Nucleares/metabolismo , Choque Séptico/metabolismo , Factores de Transcripción/metabolismo , Factor de Necrosis Tumoral alfa/metabolismo , Proteína p53 Supresora de Tumor/metabolismo , Secuencias de Aminoácidos , Secuencia de Aminoácidos , Animales , Sitios de Unión , Células Cultivadas , Proteínas de Unión al ADN , Regulación hacia Abajo , Regulación de la Expresión Génica , Humanos , Inflamación/metabolismo , Lipopolisacáridos/farmacología , Pulmón/metabolismo , Pulmón/patología , Macrófagos/efectos de los fármacos , Macrófagos/metabolismo , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Datos de Secuencia Molecular , Proteínas Nucleares/genética , Fragmentos de Péptidos/metabolismo , Fragmentos de Péptidos/farmacología , Regiones Promotoras Genéticas , Choque Séptico/patología , Factores de Transcripción/genética , Transfección , Factor de Necrosis Tumoral alfa/genética
7.
Oncogene ; 29(47): 6245-56, 2010 Nov 25.
Artículo en Inglés | MEDLINE | ID: mdl-20802531

RESUMEN

We report here a novel role for Jun dimerization protein-2 (JDP2) as a regulator of the progression of normal cells through the cell cycle. To determine the role of JDP2 in vivo, we generated Jdp2-knockout (Jdp2KO) mice by targeting exon-1 to disrupt the site of initiation of transcription. The epidermal thickening of skin from the Jdp2KO mice after treatment with 12-O-tetradecanoylphorbol 13-acetate (TPA) proceeded more rapidly than that of control mice, and more proliferating cells were found at the epidermis. Fibroblasts derived from embryos of Jdp2KO mice proliferated faster and formed more colonies than fibroblasts from wild-type mice. JDP2 was recruited to the promoter of the gene for cyclin-A2 (ccna2) at the AP-1 site. Cells lacking Jdp2 had elevated levels of cyclin-A2 mRNA. Furthermore, reintroduction of JDP2 resulted in the repression of transcription of ccna2 and of cell-cycle progression. Thus, transcription of the gene for cyclin-A2 appears to be a direct target of JDP2 in the suppression of cell proliferation.


Asunto(s)
Ciclo Celular/genética , Ciclina A2/genética , Regulación hacia Abajo , Proteínas Represoras/metabolismo , Animales , Apoptosis/genética , Línea Celular , Proliferación Celular , Ciclina A2/metabolismo , Quinasas Ciclina-Dependientes/metabolismo , Ciclinas/metabolismo , Epidermis/lesiones , Epidermis/metabolismo , Epidermis/patología , Técnicas de Inactivación de Genes , Genes Reporteros/genética , Ratones , Regiones Promotoras Genéticas/genética , Proteínas Represoras/deficiencia , Proteínas Represoras/genética
8.
Cancer Gene Ther ; 16(2): 126-36, 2009 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-18818710

RESUMEN

Combination therapy with replicative oncolytic viruses is a recent topic in innovative cancer therapy, but few studies have examined the efficacy of oncolytic adenovirus plus replication-deficient adenovirus carrying a suicide gene. We aim to evaluate whether an E1A, E1B double-restricted oncolytic adenovirus, AxdAdB-3, can improve the efficacy for gallbladder cancers (GBCs) of the replication-deficient adenovirus-based herpes simplex virus thymidine kinase (HSVtk)/ganciclovir (GCV) therapy directed by the carcinoembryonic antigen (CEA) promoter. Cytopathic effects of AxdAdB-3 plus AxCEAprTK (an adenovirus expressing HSVtk directed by CEA promoter) or AxCAHSVtk (an adenovirus expressing HSVtk directed by a nonspecific CAG promoter) with GCV administration were examined in several GBC lines and normal cells. Efficacy in vivo was tested in severe combined immunodeficiency disease mice with GBC xenografts. Addition of AxdAdB-3 (1 multiplicity of infection, MOI) significantly enhanced the cytopathic effects of AxCEAprTK (10 MOI)/GCV on GBC cells. The augmented effect was attributable to the replication of the AxCEAprTK and also to the enhanced CEA promoter activity, which was presumably transactivated by E1A. In normal cells, AxdAdB-3 (20 MOI) plus AxCEAprTK (200 MOI)/GCV was not cytopathic, whereas AxdAdB-3 (1 MOI) plus AxCAHSVtk (10 MOI)/GCV was significantly toxic. Low-dose AxdAdB-3 (2 x 10(7) PFU, plaque-forming unit) plus AxCEAprTK (2 x 10(8) PFU)/GCV significantly suppressed the growth of GBC xenografts as compared with either AxdAdB-3 (2 x 10(7) PFU)/GCV or AxCEAprTK (2 x 10(9) PFU)/GCV alone. E1A, E1B double-restricted replicating adenovirus at low dose significantly augmented the efficacy of CEA promoter-directed HSVtk/GCV therapy without obvious toxicity to normal cells, suggesting a potential use of this combination for treating GBC and other CEA-producing malignancies.


Asunto(s)
Adenoviridae/metabolismo , Proteínas E1A de Adenovirus/metabolismo , Proteínas E1B de Adenovirus/metabolismo , Neoplasias de la Vesícula Biliar/terapia , Terapia Genética/métodos , Viroterapia Oncolítica , Replicación Viral , Adenoviridae/genética , Proteínas E1A de Adenovirus/genética , Proteínas E1B de Adenovirus/genética , Animales , Antígeno Carcinoembrionario/genética , Antígeno Carcinoembrionario/metabolismo , Línea Celular Tumoral , Femenino , Neoplasias de la Vesícula Biliar/genética , Neoplasias de la Vesícula Biliar/virología , Células HeLa , Humanos , Ratones , Ratones SCID
9.
Cell Death Differ ; 14(8): 1398-405, 2007 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-17464331

RESUMEN

Among the events that control cellular differentiation, the acetylation of histones plays a critical role in the regulation of transcription and the modification of chromatin. Jun dimerization protein 2 (JDP2), a member of the AP-1 family, is an inhibitor of such acetylation and contributes to the maintenance of chromatin structure. In an examination of Jdp2 'knock-out' (KO) mice, we observed elevated numbers of white adipocytes and significant accumulation of lipid in the adipose tissue in sections of scapulae. In addition, mouse embryo fibroblasts (MEFs) from Jdp2 KO mice were more susceptible to adipocyte differentiation in response to hormonal induction and members of the CCAAT/enhancer-binding proteins (C/EBP) gene family were expressed at levels higher than MEFs from wild-type mice. Furthermore, JDP2 inhibited both the acetylation of histone H3 in the promoter of the gene for C/EBPdelta and transcription from this promoter. Our data indicate that JDP2 plays a key role as a repressor of adipocyte differentiation by regulating the expression of the gene for C/EBPdelta via inhibition of histone acetylation.


Asunto(s)
Adipocitos/citología , Adipocitos/metabolismo , Histonas/metabolismo , Proteínas Represoras/fisiología , Células 3T3-L1 , Acetilación , Adipogénesis/genética , Adipogénesis/fisiología , Animales , Secuencia de Bases , Proteína delta de Unión al Potenciador CCAAT/genética , Diferenciación Celular/fisiología , Cartilla de ADN/genética , Femenino , Fibroblastos/citología , Fibroblastos/metabolismo , Marcación de Gen , Histonas/química , Técnicas In Vitro , Masculino , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Mutación , Embarazo , Regiones Promotoras Genéticas , Proteínas Represoras/genética
10.
J Biol Chem ; 276(43): 39903-10, 2001 Oct 26.
Artículo en Inglés | MEDLINE | ID: mdl-11546757

RESUMEN

Mannosylerythritol lipid (MEL), a novel extracellular glycolipid from yeast, was found to inhibit the proliferation of mouse melanoma B16 cells in a dose-dependent manner and to induce the apoptosis of B16 cells at concentrations higher than 10 microm (Zhao, X., Wakamatsu, Y., Shibahara, M., Nomura, N., Geltinger, C., Nakahara, T., Murata, T., and Yokoyama, K. K. (1999) Cancer Res. 59, 482-486). We show here that exposure of B16 cells to MEL (5 microm) for 2 days resulted in an increase of the levels of differentiation-associated markers of melanoma cells such as melanogenesis and tyrosinase activity, which were accompanied by morphological changes. The MEL-induced differentiation of B16 cells at this concentration was closely associated with arrest of the cell cycle at G(1) phase, but no significant population of apoptotic cells was identified. Expression of protein kinase Calpha (PKCalpha) was enhanced after exposure of B16 cells to MEL for 48 h. Antisense oligodeoxynucleotides against the mouse gene for PKCalpha prevented MEL-induced melanogenesis in B16 cells. Conversely, the effects of the expression of a constitutively active form of PKCalpha mimicked the effects of MEL on B16 cells. These data suggest that MEL, a yeast-derived glycolipid, triggers the differentiation of B16 melanoma cells through a signaling pathway that involves PKCalpha.


Asunto(s)
Antineoplásicos/farmacología , Glucolípidos/farmacología , Isoenzimas/metabolismo , Melanoma Experimental/tratamiento farmacológico , Proteína Quinasa C/metabolismo , Animales , Antígenos de Diferenciación , Ciclo Celular/efectos de los fármacos , Diferenciación Celular , Melaninas/biosíntesis , Ratones , Imitación Molecular , Monofenol Monooxigenasa/biosíntesis , Oligonucleótidos Antisentido/farmacología , Fosforilación , Proteína Quinasa C-alfa , Células Tumorales Cultivadas
11.
J Histochem Cytochem ; 49(9): 1177-82, 2001 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-11511686

RESUMEN

Proteinase K is widely used in methods for detection of transcripts in biological specimens by in situ hybridization (ISH). However, treatment with proteinase K hampers detection of RNA and protein simultaneously. We have developed a method for double staining of transcripts and proteins by ISH and IHC staining in imaginal discs and embryos of Drosophila. Instead of treatment with proteinase K, samples are treated with ethanol plus xylene and with acetone. Acetone renders cell membranes permeable to probes and antibodies without damaging tissue integrity, whereas treatment with proteinase K sometimes damages tissues. Treatment of samples with acetone allows hybridization of probe with transcripts in tissue. It is also effective for immunological staining of samples after ISH with a riboprobe. Thus, our method allows detection not only of transcripts but also of specific proteins in relatively intact single samples. (J Histochem Cytochem 49:1177-1182, 2001)


Asunto(s)
Proteínas de Drosophila , Proteínas de Insectos/metabolismo , ARN/metabolismo , Acetona , Animales , Permeabilidad de la Membrana Celular , Drosophila , Embrión no Mamífero , Etanol , Proteínas de Homeodominio/metabolismo , Inmunohistoquímica/métodos , Hibridación in Situ/métodos , Indicadores y Reactivos , Proteínas de Insectos/genética , Larva , Proteínas del Tejido Nervioso/metabolismo , Proteínas Nucleares/metabolismo , Proteínas Proto-Oncogénicas/metabolismo , Factores de Transcripción/metabolismo , Proteína Wnt1 , Xilenos
12.
Biochem Biophys Res Commun ; 286(5): 1087-97, 2001 Sep 07.
Artículo en Inglés | MEDLINE | ID: mdl-11527412

RESUMEN

Expression of the DCC (deleted in colorectal cancer) protein is strongly induced during the neural differentiation of mouse P19 embryonal carcinoma (EC) cells that occurs when these cells are treated with retinoic acid (RA). Myc-associated zinc finger protein (MAZ) is a DNA-binding protein that is widely expressed and functions in human, mouse and hamster cells as an activator, an initiator or a terminator of transcription. However, the biological functions of MAZ remain elusive. We report here that MAZ associates with the cytoplasmic domain of the DCC protein in vivo and in vitro. Yeast two-hybrid assays confirmed this association. An immunofluorescence study demonstrated that DCC protein is expressed at elevated levels in neuron-like P19 EC cells, in particular in axons, in which the MAZ protein is also expressed. We found that MAZ was translocated from the nucleus to the cytoplasm during the RA-induced terminal differentiation of P19 EC cells with resultant loss of the ability of MAZ to bind to the ME1a1 site of the c-myc promoter. Taken together, our observations imply that the DCC protein might play a critical role as a signaling molecule in the regulation of the transcriptional activity of MAZ during the neural differentiation of P19 EC cells.


Asunto(s)
Moléculas de Adhesión Celular/metabolismo , Neuronas/metabolismo , Factores de Transcripción/metabolismo , Proteínas Supresoras de Tumor , Transporte Activo de Núcleo Celular , Secuencia de Aminoácidos , Animales , Sitios de Unión , Northern Blotting , Western Blotting , Diferenciación Celular , Línea Celular , Núcleo Celular/metabolismo , Citoplasma/metabolismo , Receptor DCC , Proteínas de Unión al ADN , Genes myc/genética , Humanos , Inmunohistoquímica , Microscopía Fluorescente , Modelos Biológicos , Datos de Secuencia Molecular , Plásmidos/metabolismo , Pruebas de Precipitina , Regiones Promotoras Genéticas , Unión Proteica , Estructura Terciaria de Proteína , ARN/metabolismo , ARN Mensajero/metabolismo , Receptores de Superficie Celular , Proteínas Recombinantes de Fusión/metabolismo , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Homología de Secuencia de Aminoácido , Transducción de Señal , Factores de Tiempo , Transcripción Genética , Transfección , Tretinoina/metabolismo , Técnicas del Sistema de Dos Híbridos , Xenopus , Dedos de Zinc
13.
J Biol Chem ; 276(32): 30429-34, 2001 Aug 10.
Artículo en Inglés | MEDLINE | ID: mdl-11395515

RESUMEN

The zinc finger proteins Sp1 and Myc-associated zinc finger protein (MAZ) are transcription factors that control the expression of various genes. Regulation of transcription by these factors is based on interactions between GC-rich DNA-binding sites (GGGCGG for Sp1 and GGGAGGG for MAZ) and the carboxyl-terminal zinc finger motifs of the two proteins. Sp1 and MAZ have three and six zinc fingers, respectively, and the details of their interactions with cis-elements remain to be clarified. We demonstrate here that Sp1 and MAZ interact with the same GC-rich DNA-binding sites, apparently sharing DNA-binding sites with each other. We found that the DNA binding activities of Sp1 and MAZ depended mainly on consecutive zinc fingers, namely the second and third zinc fingers in Sp1 and the third and fourth zinc fingers in MAZ. Furthermore, the interactions of the zinc finger proteins with the same cis-elements appear to play a critical role in the regulation of gene expression. It seems plausible that two consecutive zinc finger motifs in a zinc finger protein might be essential for interaction of the protein with DNA.


Asunto(s)
Factor de Transcripción Sp1/química , Factores de Transcripción/química , Células 3T3 , Secuencias de Aminoácidos , Animales , Sitios de Unión , Línea Celular , ADN/metabolismo , Proteínas de Unión al ADN , Relación Dosis-Respuesta a Droga , Glutatión Transferasa/metabolismo , Células HeLa , Humanos , Ratones , Modelos Moleculares , Plásmidos , Unión Proteica , Dedos de Zinc
14.
J Health Econ ; 20(3): 441-57, 2001 May.
Artículo en Inglés | MEDLINE | ID: mdl-11373840

RESUMEN

We conducted a field experiment comparing hypothetical and real purchase decisions for a pharmacist provided asthma management program among 172 subjects with asthma. Subjects received either a dichotomous choice contingent valuation question or were given the opportunity to actually enroll in the program. Three different prices were used: US$ 15, 40, and 80. In the hypothetical group, 38% of subjects said that they would purchase the good at the stated price, but only 12% of subjects in the real group purchased the good (p = 0.000). We cannot, however, reject the null hypothesis that "definitely sure" hypothetical yes responses, as identified in a follow-up question, correspond to real yes responses. We conclude that the dichotomous choice contingent valuation method overestimates willingness to pay, but that it may be possible to correct for this overestimation by sorting out "definitely sure" yes responses.


Asunto(s)
Asma/tratamiento farmacológico , Asma/economía , Conducta de Elección , Manejo de la Enfermedad , Financiación Personal , Aceptación de la Atención de Salud/estadística & datos numéricos , Farmacias/economía , Adolescente , Adulto , Anciano , Sesgo , Distribución de Chi-Cuadrado , Femenino , Sector de Atención de Salud , Humanos , Kentucky , Masculino , Persona de Mediana Edad , Análisis de Regresión , Encuestas y Cuestionarios
15.
Dev Biol ; 233(1): 137-47, 2001 May 01.
Artículo en Inglés | MEDLINE | ID: mdl-11319863

RESUMEN

The hiiragi (hrg) gene plays a key role in the development of the wing margin in Drosophila melanogaster. A mutation in the hrg gene resulted in a decrease in the level of the hrg transcript and was associated with a notched wing phenotype. We report here that the hrg gene encodes a poly(A) polymerase (PAP). The bovine cDNA for PAP type II reversed the phenotype due to mutation of the hrg gene, suggesting that hrg might encode a functional homolog of PAP. A mutation that reduced the enzymatic activity of Hrg failed to reverse the phenotype of hrg mutants, suggesting that the enzymatic activity of Hrg was required to rescue the wing phenotype. The levels of expression of wingless and cut at the presumptive wing margins were reduced in the late third-instar larvae of hrg mutants. These results suggest that the product of hrg is required for the normal expression of a series of genes in this region. Our results provide the first evidence that a PAP in Drosophila plays a key role in the early development of the wing margin, acting to regulate the specific expression of a series of genes via, perhaps, control of the processing of the 3' ends of transcripts.


Asunto(s)
Proteínas de Drosophila , Drosophila melanogaster/genética , Genes de Insecto , Polinucleotido Adenililtransferasa/genética , Alas de Animales/crecimiento & desarrollo , Secuencia de Aminoácidos , Animales , Secuencia de Bases , Clonación Molecular , Drosophila melanogaster/enzimología , Datos de Secuencia Molecular , Mutación , Homología de Secuencia de Aminoácido , Alas de Animales/anatomía & histología
16.
J Biol Chem ; 276(23): 19897-904, 2001 Jun 08.
Artículo en Inglés | MEDLINE | ID: mdl-11259406

RESUMEN

The transcription factors Sp1 and MAZ (Myc-associated zinc finger protein) contain several zinc finger motifs, and each functions as both a positive and a negative regulator of gene expression. In this study, we characterized the extremely GC-rich promoter of the human gene for MAZ, which is known as a housekeeping gene. Unique symmetrical motifs in the promoter region (nucleotides -383 to -334) were essential for the expression of the gene for MAZ, whereas an upstream silencer element (nucleotides -784 to -612) was found to act in a position-dependent but orientation-independent manner. Sp1 and MAZ bound to the same cis-elements in the GC-rich promoter, apparently sharing DNA-binding sites. The relative extent of binding of Sp1 and MAZ to these cis-elements corresponded to the extent of negative regulation of the expression of the gene for MAZ in various lines of cells. Furthermore, novel repressive domains in both Sp1 (amino acids 622-788) and MAZ (amino acids 127-292) were identified. Suppression by Sp1 and suppression by MAZ were independent phenomena; histone deacetylases were involved in the autorepression by MAZ itself, whereas DNA methyltransferase 1 was associated with suppression by Sp1. Our results indicate that both deacetylation and methylation might be involved in the regulation of expression of a single gene via the actions of different zinc finger proteins that bind to the same cis-elements.


Asunto(s)
Regulación de la Expresión Génica/fisiología , Proteínas Proto-Oncogénicas c-myc/fisiología , Factor de Transcripción Sp1/fisiología , Factores de Transcripción/genética , Factores de Transcripción/fisiología , Animales , Secuencia de Bases , Línea Celular , ADN , Proteínas de Unión al ADN , Histona Desacetilasas/metabolismo , Humanos , Datos de Secuencia Molecular , Pruebas de Precipitina , Regiones Promotoras Genéticas , Dedos de Zinc
17.
FEBS Lett ; 489(1): 34-41, 2001 Jan 26.
Artículo en Inglés | MEDLINE | ID: mdl-11231009

RESUMEN

A mouse cDNA that encodes a DNA-binding protein was identified by yeast two-hybrid screening, using activating transcription factor-2 (ATF-2) as the bait. The protein contained a bZIP (basic amino acid-leucine zipper region) domain and its amino acid sequence was almost identical to that of rat Jun dimerization protein 2 (JDP2). Mouse JDP2 interacted with ATF-2 both in vitro and in vivo via its bZIP domain. It was encoded by a single gene and various transcripts were expressed in all tested tissues of adult mice, as well as in embryos, albeit at different levels in various tissues. Furthermore, mouse JDP2 bound to the cAMP-response element (CRE) as a homodimer or as a heterodimer with ATF-2, and repressed CRE-dependent transcription that was mediated by ATF-2. JDP2 was identified as a novel repressor protein that affects ATF-2-mediated transcription.


Asunto(s)
Proteína de Unión a Elemento de Respuesta al AMP Cíclico/genética , Proteínas Represoras/aislamiento & purificación , Factores de Transcripción/genética , Células 3T3 , Factor de Transcripción Activador 2 , Secuencia de Aminoácidos , Animales , Proteína de Unión a Elemento de Respuesta al AMP Cíclico/metabolismo , Proteína de Unión a Elemento de Respuesta al AMP Cíclico/fisiología , Expresión Génica , Silenciador del Gen , Ratones , Datos de Secuencia Molecular , Proteínas Represoras/biosíntesis , Proteínas Represoras/genética , Proteínas Represoras/fisiología , Homología de Secuencia de Aminoácido , Factores de Transcripción/metabolismo , Transcripción Genética , Técnicas del Sistema de Dos Híbridos
18.
Biochem Biophys Res Commun ; 281(4): 1041-4, 2001 Mar 09.
Artículo en Inglés | MEDLINE | ID: mdl-11237769

RESUMEN

To study the Hoxa-13 gene in the liver, we examined its expression by RT-PCR in various liver cell lines, rat livers under different conditions, and human primary hepatocellular carcinomas (HCCs). The gene was found to be expressed in cell lines originating from liver stem-like cells, but not in cell lines originating from hepatocytes and bile duct epithelia. Expression was induced in rat livers after treatment with d-galactosamine, which is known to induce oval cell proliferation, but not after a two-thirds partial hepatectomy (2/3 PH) where induction of oval cell proliferation is thought not to occur. Expression of the gene correlated with human HCC samples associated with Hepatitis B or C virus infection in this small series. These results suggest that the Hoxa-13 gene may provide a potentially useful tool for elucidation of mechanisms involved in lineage-specific differentiation and carcinogenesis of liver stem cells.


Asunto(s)
Carcinoma Hepatocelular/genética , Proteínas de Homeodominio/genética , Neoplasias Hepáticas/genética , Animales , Carcinoma Hepatocelular/patología , Carcinoma Hepatocelular/virología , Línea Celular , Galactosamina/farmacología , Regulación Neoplásica de la Expresión Génica , Hepacivirus , Hepatectomía , Virus de la Hepatitis B , Hepatitis Viral Humana/genética , Hepatitis Viral Humana/virología , Humanos , Hígado/citología , Hígado/efectos de los fármacos , Hígado/metabolismo , Neoplasias Hepáticas/patología , Neoplasias Hepáticas/virología , ARN Mensajero/genética , ARN Mensajero/metabolismo , ARN Neoplásico/genética , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Células Tumorales Cultivadas
19.
Gene ; 264(1): 19-27, 2001 Feb 07.
Artículo en Inglés | MEDLINE | ID: mdl-11245974

RESUMEN

Transcription factor Sp4 is a member of the Sp1 family. It functions differently from other members of this family, such as Sp1 and Sp3, and the gene for Sp4 is transcribed in a tissue-specific manner. Recent studies in mice suggest that Sp4 might play an important role in growth, viability, and male fertility. We report here the isolation and characterization of the gene for Sp4 from a mouse genomic library. The mouse gene for Sp4 was about 80 kb in length and it consisted of six exons and five introns. The promoter was found in a CpG island and had a high G+C content. The proximal promoter contained multiple putative binding sites for the transcription factors Sp1 and MAZ but lacked a consensus TATA box. Multiple sites for the initiation of transcription were mapped in a GC-rich region from 286 bp to 211 bp upstream of the ATG triplet at the site of initiation of translation, and all of the sites were either C or G. Transfection experiments and deletion analysis allowed us to localize the promoter to a region that was no more than 93 bp upstream from the first site of initiation of transcription. We also found that ectopic expression of Sp1 and of MAZ, but not of Sp3, suppressed expression of the Sp4 promoter in a dose-dependent manner.


Asunto(s)
Regiones Promotoras Genéticas/genética , Factores de Transcripción/genética , Secuencia de Aminoácidos , Animales , Secuencia de Bases , Línea Celular , ADN/química , ADN/genética , ADN/aislamiento & purificación , Proteínas de Unión al ADN/metabolismo , Regulación de la Expresión Génica , Humanos , Luciferasas/genética , Luciferasas/metabolismo , Ratones , Datos de Secuencia Molecular , Unión Proteica , Proteínas Recombinantes de Fusión/genética , Proteínas Recombinantes de Fusión/metabolismo , Alineación de Secuencia , Análisis de Secuencia de ADN , Eliminación de Secuencia , Homología de Secuencia de Ácido Nucleico , Factor de Transcripción Sp1/metabolismo , Factor de Transcripción Sp3 , Factor de Transcripción Sp4 , Factores de Transcripción/metabolismo , Transcripción Genética
20.
Biochim Biophys Acta ; 1518(1-2): 183-9, 2001 Mar 19.
Artículo en Inglés | MEDLINE | ID: mdl-11267677

RESUMEN

il-TMP (also known as TM4SF4) is a human tetraspanin that is expressed in human intestine and liver. We have cloned a novel cDNA for a rat gene with sequence similar to that of a cDNA for human il-TMP. The cDNA encoded a protein of 202 amino acids, designated rat TM4SF4. The corresponding transcript was detected in rat liver and testis. The expression of rat TM4SF4 was enhanced in regenerating liver after two-thirds partial hepatectomy. It was supposed that rat TM4SF4 might play a role in cell proliferation and in liver regeneration.


Asunto(s)
Regeneración Hepática , Hígado/metabolismo , Glicoproteínas de Membrana/genética , Proteínas de la Membrana/genética , Secuencia de Aminoácidos , Animales , Secuencia de Bases , Clonación Molecular , ADN Complementario , Regulación de la Expresión Génica , Humanos , Hígado/fisiología , Glicoproteínas de Membrana/metabolismo , Proteínas de la Membrana/metabolismo , Ratones , Datos de Secuencia Molecular , Ratas , Homología de Secuencia de Aminoácido , Distribución Tisular
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...